KCI Biotech(SUZHOU).Inc.
凯斯艾生物
KCI Biotech(SUZHOU).Inc.
Biotech/Healthcare
Kaisi'ai Bio is a pharmacodynamics research CRO focused on non-oncology diseases, including cardiovascular and cerebrovascular conditions, inflammation, immune and metabolic diseases, and liver and kidney diseases. It provides experimental animal model development, preclinical pharmacology and…
Latest round: Series B (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-06-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.